Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

CellGenTek Co Ltd (258250)

KONEX
Currency in KRW
Disclaimer
2,545
-10(-0.39%)
Closed
258250 Scorecard
Fair Value
Unlock Value
Day's Range
2,4002,900
52 wk Range
1,9556,220
Bid/Ask
2,455.00 / 2,545.00
Prev. Close
2,555
Open
2,600
Day's Range
2,400-2,900
52 wk Range
1,955-6,220
Volume
2,218
Average Volume (3m)
10,137
1-Year Change
-48%
Shares Outstanding
3,919,548
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about 258250?
Vote to see community's results!
or

CellGenTek Co Ltd Company Profile

CELLGENTEK Co., Ltd. engages in the production of medical analysis equipment and systems. Its products include FOBI, a device that can image and analyze fluorescent signals from tissues and organisms; CheBIis, which is optimized for western blot research, using the highly efficient cooling CCD camera; and FluoroBox, a nucleic acid bioimaging instrument. It also offers NK cell therapy, an anticancer drug by using gene manipulation NK cell. In addition, it provides personalized medical service for cancer diagnosis, treatment, and prognosis management. The company was formerly known as PCPIA BIT Co.,Ltd. and changed its name to CELLGENTEK Co., Ltd. in 2018. CELLGENTEK Co., Ltd. was founded in 2002 and is headquartered in Cheongju-Si, South Korea.

Employees
0
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.